Viper™ Katheta za Uingizaji wa Valve

Viper™ Katheta za Uingizaji wa Valve

The Viper™ Catheter ya Uingizaji wa Valivu ni a moja-lumen, ncha ya valved mfumo wa utoaji ambao hutoa kubadilika kwa kupenyeza mawakala wa kupambana na thrombus, tofauti ya radiopaque, au ufumbuzi mwingine wa pharmacologic ulioainishwa na daktari na au bila waya wa mwongozo mahali.

Habari

The Viper™ Catheter ya Uingizaji wa Valivu ni a moja-lumen, ncha ya valved mfumo wa utoaji ambao hutoa kubadilika kwa kupenyeza mawakala wa kupambana na thrombus, tofauti ya radiopaque, au ufumbuzi mwingine wa pharmacologic ulioainishwa na daktari na au bila a guidewire in place. By eliminating the need for a tip-occluding wire during treatment, Viper™ greatly expands the available infusion lumen, allowing higher flow rates and more efficient coverage of targeted vessel segments. Offered in 4F na 5F sizes and multiple lengths, Viper™ catheters are specifically intended for kudhibitiwa na kuchagua delivery of agents into the general vasculature—excluding coronary, pediatric, or neonatal applications.

Valved-Tip Construction
  • Flexible Infusion Options: The valve at the distal tip enables fluid infusion directly through the catheter lumen, even in the absence of a guidewire.
  • Improved Lumen Area: By avoiding a tip-occluding guidewire during treatment, the infusion pathway effectively doubles in diameter (compared to catheters requiring a wire in place), enhancing infusion capacity.
  • Large Infusion Lumen: Facilitates high-flow infusion of anti-thrombus agents or radiopaque contrast.
  • Enhanced Deliverability: Maintains a low-profile catheter body for streamlined advancement through tortuous vessels.
  • 4F & 5F Catheters: Address the needs of diverse peripheral vessel diameters—choose the size that best aligns with procedural goals.
  • Various Usable Lengths: Available in multiple lengths (consult device labeling) to accommodate short or extended lesion coverage and different access sites.
  • Adaptable: Suitable for physician-specified pharmacologic agents (e.g., thrombolytics, vasodilators) or routine contrast media.
  • Standard IFU Compliance: Pharmacologic agents should be prepared and administered per each drug’s instructions for use to ensure safe infusion.
  • Flexible Infusion Options: The valve at the distal tip enables fluid infusion directly through the catheter lumen, even in the absence of a guidewire.
  • Improved Lumen Area: By avoiding a tip-occluding guidewire during treatment, the infusion pathway effectively doubles in diameter (compared to catheters requiring a wire in place), enhancing infusion capacity.
  • Large Infusion Lumen: Facilitates high-flow infusion of anti-thrombus agents or radiopaque contrast.
  • Enhanced Deliverability: Maintains a low-profile catheter body for streamlined advancement through tortuous vessels.
  • 4F & 5F Catheters: Address the needs of diverse peripheral vessel diameters—choose the size that best aligns with procedural goals.
  • Various Usable Lengths: Available in multiple lengths (consult device labeling) to accommodate short or extended lesion coverage and different access sites.
  • Adaptable: Suitable for physician-specified pharmacologic agents (e.g., thrombolytics, vasodilators) or routine contrast media.
  • Standard IFU Compliance: Pharmacologic agents should be prepared and administered per each drug’s instructions for use to ensure safe infusion.

Vipimo vya Bidhaa

Vipimo Maelezo / Thamani
Jina la Bidhaa Viper ULTRA Thrombolysis Catheter
Matumizi yaliyokusudiwa Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial)
Ubunifu wa Catheter Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip
Nyenzo Pebax/Polyamide shaft, potentially braided or reinforced
Kipenyo cha Nje (F) ~4–6F (depending on infusion lumen capacity)
Urefu wa Kufanya Kazi ~80–150 cm (varies by product code)
Infusion Ports Distributed side ports over a defined segment for consistent thrombolytic delivery
Utangamano wa Mwongozo Typically 0.014” or 0.018”
Kuzaa Tasa, Matumizi Moja
Maisha ya Rafu ~2–3 years if stored at 15–25 °C in sealed packaging
Dalili za Kliniki Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis
Contraindications Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies

Matrix ya Kuagiza & Ukubwa

Kipenyo cha Nje (F) Urefu wa Kufanya kazi (cm) Infusion Segment (cm) Kanuni ya Bidhaa Vidokezo
4F 80 10 VPR-4F-80-10 Smaller OD for distal or small vessel usage
4F 120 15 VPR-4F-120-15 Longer shaft, moderate infusion segment
5F 80 10 VPR-5F-80-10 Slightly larger OD for heavier clot load
5F 120 20 VPR-5F-120-20 Extended length with longer infusion zone
6F 100 15 VPR-6F-100-15 Common size for multi-level peripheral lesions
6F 150 30 VPR-6F-150-30 Max length, extensive infusion segment

Bidhaa zinazohusiana